Nanoparticle drug delivery systems and their use in cardiac tissue therapy

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Regenerative Medicine

Background:

• Cardiovascular diseases, including myocardial infarction, are leading causes of mortality.
• Current treatments for myocardial infarction are often palliative, leading to heart failure.
• Heart transplantation is limited by donor organ scarcity, necessitating alternative repair strategies.

Purpose of the Study:

• To review alternative treatments for myocardial infarction using nanoparticle-based drug delivery.
• To explore the use of chemokines and drugs delivered via nanoparticles for cardiac repair.
• To assess the efficacy and clinical translation challenges of these nanoparticulate systems.

Main Methods:

• Literature review of studies on nanoparticulate drug delivery for myocardial infarction.
• Analysis of therapeutic strategies involving chemokines and drugs encapsulated in nanoparticles.
• Evaluation of reported efficacy and clinical challenges.

Main Results:

• Nanoparticle systems offer a promising approach for delivering therapeutic agents to the infarcted heart.
• Chemokine and drug delivery via nanoparticles can promote revascularization and cardiac repair.
• Existing studies show potential but face challenges in clinical translation.

Conclusions:

• Nanoparticle-mediated drug delivery represents a viable alternative strategy for myocardial infarction treatment.
• Further investigation is required to overcome challenges and enable widespread clinical use.
• This approach holds potential for improving outcomes in patients with ischemic heart disease.